Deutetrabenazine-Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease

JAMA Neurol. 2016 Dec 1;73(12):1404-1406. doi: 10.1001/jamaneurol.2016.3916.

Author

Ralf Reilmann¹

Affiliation

¹ George-Huntington-Institute, Muenster, Germany2Department of Radiology, University of Muenster, Muenster, Germany3Department of Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany4Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.

PMID: 27749952
DOI: 10.1001/jamaneurol.2016.3916

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Huntington Disease / drug therapy*
Neurotransmitter Uptake Inhibitors / therapeutic use*
Tetrabenazine / analogs & derivatives*
Tetrabenazine / therapeutic use

Substances

Neurotransmitter Uptake Inhibitors
deutetrabenazine
Tetrabenazine